Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 29 studies | 36% ± 16% | |
| endothelial cell | 10 studies | 23% ± 5% | |
| connective tissue cell | 7 studies | 38% ± 12% | |
| vein endothelial cell | 7 studies | 24% ± 8% | |
| endothelial cell of artery | 7 studies | 34% ± 14% | |
| adventitial cell | 5 studies | 53% ± 19% | |
| adipocyte | 5 studies | 22% ± 8% | |
| glial cell | 3 studies | 27% ± 10% | |
| endothelial cell of vascular tree | 3 studies | 25% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipose | 4 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 20545.11 | 459 / 459 | 96% | 118.73 | 1070 / 1118 |
| thymus | 97% | 14102.73 | 636 / 653 | 78% | 29.32 | 472 / 605 |
| bladder | 100% | 13115.24 | 21 / 21 | 65% | 37.45 | 330 / 504 |
| skin | 98% | 19196.99 | 1765 / 1809 | 67% | 32.85 | 317 / 472 |
| esophagus | 88% | 10423.16 | 1277 / 1445 | 73% | 46.42 | 133 / 183 |
| prostate | 78% | 5683.87 | 190 / 245 | 83% | 37.95 | 415 / 502 |
| lung | 73% | 5674.19 | 424 / 578 | 86% | 54.29 | 989 / 1155 |
| uterus | 74% | 5266.02 | 126 / 170 | 78% | 56.64 | 359 / 459 |
| intestine | 71% | 5674.10 | 685 / 966 | 63% | 32.81 | 333 / 527 |
| stomach | 41% | 3336.11 | 147 / 359 | 69% | 38.47 | 196 / 286 |
| adipose | 100% | 28380.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 96% | 12974.22 | 1277 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 2% | 78.23 | 6 / 328 | 93% | 86.72 | 166 / 178 |
| heart | 95% | 25095.68 | 817 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 87% | 69.49 | 39 / 45 |
| ovary | 8% | 625.05 | 15 / 180 | 59% | 29.00 | 255 / 430 |
| kidney | 9% | 341.55 | 8 / 89 | 51% | 22.37 | 461 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 19.24 | 17 / 29 |
| muscle | 56% | 3035.08 | 447 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 177.36 | 13 / 258 | 50% | 15.97 | 115 / 230 |
| liver | 0% | 14.43 | 1 / 226 | 36% | 12.62 | 146 / 406 |
| brain | 0% | 19.95 | 13 / 2642 | 15% | 4.94 | 107 / 705 |
| eye | 0% | 0 | 0 / 0 | 15% | 3.13 | 12 / 80 |
| spleen | 2% | 54.56 | 4 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
| GO_1903561 | Cellular component | extracellular vesicle |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0030023 | Molecular function | extracellular matrix constituent conferring elasticity |
| GO_0050840 | Molecular function | extracellular matrix binding |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FBLN2 |
| Protein name | Fibulin 2 Truncated fibulin 2 Fibulin-2 (FIBL-2) |
| Synonyms | |
| Description | FUNCTION: Its binding to fibronectin and some other ligands is calcium dependent. May act as an adapter that mediates the interaction between FBN1 and ELN . . |
| Accessions | ENST00000404922.8 [P98095-2] D9ZGF4 H7BXL0 ENST00000295761.11 P98095 ENST00000492059.5 [P98095-2] H7C1A3 Q86V58 C9JQS6 ENST00000421373.1 ENST00000295760.11 [P98095-1] ENST00000465610.1 |
